100.31

1.95% 1.92

Pre-market: 99.51 -0.80 -0.80%

Biontech Se Adr (BNTX)

Overview News Price History Option Chain Why BNTX Down? Discussions Forecast Dividend History

Biontech Se Adr stock is traded at $100.31, with a volume of 1.21M. It is up +1.95% in the last 24 hours and down -10.35% over the past month. BioNTech is a Germany-based biotechnology company that focuses on developing cancer therapeutics, including individualized immunotherapy, as well as vaccines for infectious diseases, including covid. The company's oncology pipeline contains several classes of drugs, including mRNA-based drugs to encode antigens, neoantigens, cytokines, and antibodies; cell therapies; bispecific antibodies; and antibody-drug conjugates, or ADCs. BioNTech is partnered with several large pharmaceutical companies, including Roche, Eli Lilly, Pfizer, Sanofi, and Genmab. Covid vaccine Comirnaty is its first commercialized product.

Previous Close:

$98.39

Open:

$100.13

24h Volume:

1.21M

Relative Volume:

1.70

Market Cap:

$24.07B

Revenue:

$3.30B

Net Income/Loss:

$-501.07M

P/E Ratio:

-47.44

EPS:

-2.1146

Net Cash Flow:

$1.03B

1W Performance:

-12.60%

1M Performance:

-10.35%

6M Performance:

-4.47%

1Y Performance:

+4.78%

1-Day Range:

$97.82

$101.08

1-Week Range:

$97.82

$113.24

52-Week Range:

$76.53

$131.49

Biontech Se Adr Stock (BNTX) Company Profile

Name

Biontech Se Adr

Sector

Healthcare (1172)

Industry

Biotechnology (680)

Phone

Address

Employee

6,772

Twitter

@BioNTech_Group

Next Earnings Date

2025-03-10

Latest SEC Filings

BNTX's Discussions on Twitter

Compare BNTX with other stocks

Stocks	Price	Market Cap	Revenue	Net Income	Cash Flow	EPS
BNTX Biontech Se Adr	100.31	24.07B	3.30B	-501.07M	1.03B	-2.1146
VRTX Vertex Pharmaceuticals Inc	495.42	127.22B	11.02B	-535.60M	-978.00M	-2.20
REGN Regeneron Pharmaceuticals Inc	689.50	75.38B	14.20B	4.41B	3.54B	38.28
ARGX Argen X Se Adr	591.45	35.94B	2.19B	833.04M	-1.28B	12.71
ALNY Alnylam Pharmaceuticals Inc	242.43	31.38B	2.25B	-278.16M	-42.59M	-2.17
ONC Beigene Ltd Adr	249.84	26.84B	3.32B	-860.46M	-1.04B	-8.32

Biontech Se Adr Stock (BNTX) Upgrades & Downgrades

Date	Action	Analyst	Rating Change
Jan-10-25	Initiated	Truist	Buy
Dec-11-24	Initiated	Wells Fargo	Overweight
Dec-02-24	Reiterated	BMO Capital Markets	Outperform
Nov-19-24	Initiated	Berenberg	Buy
Nov-19-24	Upgrade	Evercore ISI	In-line → Outperform
Nov-08-24	Upgrade	Goldman	Neutral → Buy
Sep-24-24	Upgrade	Morgan Stanley	Equal-Weight → Overweight
Sep-17-24	Upgrade	Jefferies	Hold → Buy
Sep-16-24	Upgrade	JP Morgan	Underweight → Neutral
Aug-07-24	Upgrade	Deutsche Bank	Hold → Buy
Aug-02-24	Upgrade	HSBC Securities	Hold → Buy
May-14-24	Initiated	Evercore ISI	In-line
Feb-23-24	Initiated	BMO Capital Markets	Outperform
Jan-05-24	Initiated	Oppenheimer	Perform
Dec-01-23	Downgrade	JP Morgan	Neutral → Underweight
Oct-16-23	Downgrade	HSBC Securities	Buy → Hold
Jul-14-23	Initiated	HSBC Securities	Buy
May-17-23	Upgrade	Redburn	Neutral → Buy
Dec-15-22	Upgrade	BofA Securities	Neutral → Buy
Aug-17-22	Initiated	Cowen	Market Perform
Jul-13-22	Upgrade	SVB Leerink	Mkt Perform → Outperform
Jul-06-22	Resumed	Canaccord Genuity	Buy
Feb-01-22	Upgrade	Redburn	Sell → Neutral
Dec-16-21	Initiated	Morgan Stanley	Equal-Weight
Nov-10-21	Upgrade	H.C. Wainwright	Neutral → Buy
Oct-22-21	Initiated	Deutsche Bank	Hold
Oct-07-21	Initiated	Jefferies	Hold
Aug-11-21	Upgrade	Bryan Garnier	Neutral → Buy
Jul-19-21	Resumed	Wolfe Research	Outperform
Jun-16-21	Downgrade	Redburn	Neutral → Sell
May-18-21	Initiated	Goldman	Neutral
May-11-21	Downgrade	Bryan Garnier	Buy → Neutral
Dec-01-20	Downgrade	BofA Securities	Buy → Neutral
Aug-03-20	Resumed	Berenberg	Buy
Jul-21-20	Upgrade	BofA Securities	Neutral → Buy
Jun-30-20	Downgrade	H.C. Wainwright	Buy → Neutral
May-19-20	Upgrade	H.C. Wainwright	Neutral → Buy
Apr-28-20	Downgrade	BofA/Merrill	Buy → Neutral
Mar-18-20	Downgrade	JP Morgan	Overweight → Neutral
Mar-09-20	Initiated	H.C. Wainwright	Neutral
Jan-24-20	Downgrade	SVB Leerink	Outperform → Mkt Perform
Jan-22-20	Downgrade	UBS	Buy → Neutral
Nov-05-19	Initiated	Wolfe Research	Outperform
Nov-04-19	Initiated	Berenberg	Buy
Nov-04-19	Initiated	BofA/Merrill	Buy
Nov-04-19	Initiated	Canaccord Genuity	Buy
Nov-04-19	Initiated	JP Morgan	Overweight
Nov-04-19	Initiated	SVB Leerink	Outperform
Nov-04-19	Initiated	UBS	Buy

View All

Biontech Se Adr Stock (BNTX) Latest News

Mar 11, 2025

Jefferies maintains BioNTech stock Buy rating, $149 target - Investing.com India

Mar 10, 2025

Earnings call transcript: BioNTech beats Q4 2024 expectations, stock dips - Investing.com

Mar 10, 2025

BioNTech Surpasses Q4 Revenue Estimates - The Motley Fool

Mar 10, 2025

US Stocks Likely To Open Lower After Trump Hints At Looming Recession: Expert Says Can't Rule Out A Bear Market As Indices Inch Towards Correction Territory - Benzinga

Mar 10, 2025

BioNTech reports Q4 EPS EUR 1.08 vs. EUR 1.88 last year - TipRanks

Mar 10, 2025

Mar 07, 2025

BioNTech's mRNA Technology and Acquired Oncology Programs Could Support a Future Moat - Morningstar

Mar 07, 2025

Mar 06, 2025

Here's Why Moderna Stock Soared 16% On Wednesday - Barchart

Mar 06, 2025

Here's Why Moderna Stock Soared 16% on Wednesday - Yahoo Finance

Mar 06, 2025

BioNTech SE's RNA-based vaccine for malaria placed on clinical hold by FDA - MSN

Mar 06, 2025

Paramount Group Inc (PGRE) Shares Soar Above 1-Year High - The News Heater

Mar 06, 2025

Mar 05, 2025

Pfizer and BioNTech violated COVID-19 vaccine patent held by Moderna, German court rules - The Globe and Mail

Mar 05, 2025

Mar 04, 2025

BioNTech stock falls after FDA clinical hold on malaria vaccine trial - Investing.com

Mar 04, 2025

Feb 27, 2025

BioNTech SEADR to Host Earnings Call - ACCESS Newswire

Feb 27, 2025

Feb 19, 2025

AASTOCKS Financial NewsBioNTech SE (BNTX) - AASTOCKS.com

Feb 19, 2025

Feb 15, 2025

Are Medical Stocks Lagging Auna S.A. (AUNA) This Year? - MSN

Feb 15, 2025

Feb 13, 2025

What Makes BioNTech (BNTX) a New Buy Stock - Yahoo Finance UK

Feb 13, 2025

Feb 06, 2025